additive hazards model
Recently Published Documents


TOTAL DOCUMENTS

100
(FIVE YEARS 35)

H-INDEX

11
(FIVE YEARS 2)

2021 ◽  
Vol 12 ◽  
Author(s):  
Yidan Cui ◽  
Chengwen Luo ◽  
Linghao Luo ◽  
Zhangsheng Yu

Mediation analysis has been extensively used to identify potential pathways between exposure and outcome. However, the analytical methods of high-dimensional mediation analysis for survival data are still yet to be promoted, especially for non-Cox model approaches. We propose a procedure including “two-step” variable selection and indirect effect estimation for the additive hazards model with high-dimensional mediators. We first apply sure independence screening and smoothly clipped absolute deviation regularization to select mediators. Then we use the Sobel test and the BH method for indirect effect hypothesis testing. Simulation results demonstrate its good performance with a higher true-positive rate and accuracy, as well as a lower false-positive rate. We apply the proposed procedure to analyze DNA methylation markers mediating smoking and survival time of lung cancer patients in a TCGA (The Cancer Genome Atlas) cohort study. The real data application identifies four mediate CpGs, three of which are newly found.


2021 ◽  
Vol 10 (1) ◽  
pp. 143-155
Author(s):  
Ling Chen ◽  
Chengjie Xiong ◽  
J. Philip Miller ◽  
Feng Gao

2021 ◽  
pp. 096228022110239
Author(s):  
Dongxiao Han ◽  
Lianqiang Qu ◽  
Liuquan Sun ◽  
Yanqing Sun

In HIV vaccine efficacy trials, mark-specific hazards models have important applications and can be used to evaluate the strain-specific vaccine efficacy. Additive hazards models have been widely used in practice, especially when continuous covariates are present. In this article, we conduct variable selection for a mark-specific additive hazards model. The proposed method is based on an estimating equation with the first derivative of the adaptive LASSO penalty function. The asymptotic properties of the resulting estimators are established. The finite sample behavior of the proposed estimators is evaluated through simulation studies, and an application to a dataset from the first HIV vaccine efficacy trial is provided.


2021 ◽  
Vol 10 (1) ◽  
pp. 143-155
Author(s):  
Ling Chen ◽  
Chengjie Xiong ◽  
J. Philip Miller ◽  
Feng Gao

Sign in / Sign up

Export Citation Format

Share Document